Category
ANTIBIOTIC
ANTIBIOTIC
Consistent
Purity
Global-Ready
Molecules
Advanced
Manufacturing
Scalable
Production
Partnership
Support
Cycloserine API has been developed by ASANA Pharmaceutical as part of its targeted anti-infective product line. Cycloserine API, identified by CAS number 68-41-7, is a broad-spectrum antibiotic primarily used in the treatment of drug-resistant tuberculosis and certain urinary tract infections.
ASANA Pharmaceutical is committed to the development and manufacturing of high-purity antibiotic APIs, including Cycloserine. With a focus on antimicrobials for resistant infections and global public health needs, ASANA ensures full regulatory alignment and reliable batch consistency. Our infrastructure serves clients across North America, Europe, and Asia, backed by stringent quality systems and scalable production capacity.
ASANA Pharmaceutical collaborates with global partners in infectious disease research and hospital-focused formulation companies to provide effective antibiotic APIs. Cycloserine [CAS No. 68-41-7] is a second-line antibiotic used in the treatment of multidrug-resistant tuberculosis and other severe bacterial infections. It forms a key part of ASANA’s antimicrobial portfolio, supporting programs in both public and private healthcare sectors. As antimicrobial resistance remains a global challenge, ASANA is dedicated to delivering:
Cycloserine API are available on public databases such as Wikipidia!